Top compounds associated with response to OCLN


Feature Type Standardized
Nominal ANOVA
mRNA Crizotinib gCSI pan-cancer AAC -0.034 0.7
mRNA nintedanib CTRPv2 pan-cancer AAC -0.019 0.7
mRNA Compound 7d-cis CTRPv2 pan-cancer AAC -0.019 0.7
mRNA MS-275 gCSI pan-cancer AAC 0.031 0.7
mRNA SR1001 CTRPv2 pan-cancer AAC -0.019 0.7
mRNA thalidomide CTRPv2 pan-cancer AAC -0.027 0.7
mRNA myriocin CTRPv2 pan-cancer AAC 0.037 0.7
mRNA spautin-1 CTRPv2 pan-cancer AAC 0.019 0.7
mRNA navitoclax:PLX-4032 (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.018 0.7
mRNA MK-2206 CTRPv2 pan-cancer AAC 0.017 0.7
Download CSV